Catalyst Wire Dossier Catalyst Wire Dossier

TCR alpha-beta T-cell and CD19 B-cell depleted peripheral blood stem cell transplantation

TCR alpha-beta T-cell and CD19 B-cell depleted PBSC transplantation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCR alpha-beta T-cell and CD19 B-cell depleted peripheral blood stem cell transplantation, covering 2021-02-24 to 2021-02-24. Get the full timeline:

Most recent: Clinical Trial Update: TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors [Phase 2]

See pricing